Login

Company overview with CEO | Phil Hartstein , President & CEO at FINJAN HOLDINGS, INC. 00:10:00

Share On Facebook Share On Twitter

Phil Hartstein is a President & CEO at FINJAN HOLDINGS, INC.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Rachel Stephanie, Director of PT M Cash Integrasi Tbk (MCAS), announced that the company has budgeted capital expenditures for the year.
00:10:00
From Executive Recruiter to Financial Advisor: Michael Hartsman's Journey in Building Lasting Client Relationships
00:10:00
Employee 1st Impact: Insights from H&E Equipment Services CEO | Bradley W. Barber - Chief Executive Officer and Director of H&E Equipment Services, Inc.
00:10:00
Scotiabank CEO Scott Thompson on Strategic Vision and Navigating North American Markets | Scott Thompson, CEO, Scotiabank.
00:10:00
Legacy Financial Strategies: Expert Wealth Management for Seniors Since 1970 | Dave gner, Founder, Legacy Financial Strategies, Inc.
00:10:00
Step Gold Finalizes Transformational Boroo Gold Acquisition
00:10:00
McFarlane Lake Mining CEO Mark Trevisiol discusses plans for exploration and development of gold properties in Canada, including an upsized private placement for further exploration near Ontario/Manitoba border.|Mark Trevisiol President, CEO of McFarlane
00:10:00
helping our portfolio companies grow their businesses and our operating teams|David Haber,General Partner,Andreessen Horowitz
00:10:00
Aramark CEO John Zillmer Partners with American Heart Association for Healthy for Life Initiative | John Zillmer, CEO, Aramark.
00:10:00
Full-Year Results Highlight Strong Financial Performance and Growth Strategy for Wind Farm Operator | Stephen Lilley, Fund manager, Greencoat UK Wind PLC.
00:10:00
Introducing Fryar Financial's Seven-Pillar Approach to Achieving Financial Independence
00:10:00
Investing in Middle-Market Private Equity with Data-Driven Decisions

© 2026 Nehu